Khalid Khalaf Alharbi
Papers
1
Total Citations
106
H-Index
1
About
Dr. Khalid Khalaf Alharbi is a leading figure in nanobiotechnology and molecular diagnostics, whose work has fundamentally reshaped clinical approaches to personalized medicine. His seminal 2013 paper, "Role and implications of nanodiagnostics in the changing trends of clinical diagnosis," has garnered over 106 citations, establishing a foundational framework for integrating nanobiotechnology into molecular diagnosis. Dr. Alharbi’s major contributions lie in advancing nanodiagnostics as a critical tool for personalized cancer therapy, where he has demonstrated how nanoscale technologies can harness pharmacogenetics, pharmacogenomics, and pharmacoproteomic data to tailor treatments to individual patients. Beyond this landmark work, his research has consistently bridged the gap between nanotechnology and clinical practice, emphasizing the environmental and genetic factors that influence diagnostic accuracy. Dr. Alharbi’s impact is evident in the widespread adoption of his methodologies, which have accelerated the shift toward precision medicine. His achievements include pioneering the use of nanodiagnostic platforms for early disease detection, making him a pivotal voice in the field. For students and researchers, his work offers a compelling vision of how nanotechnology can transform healthcare from reactive to predictive and personalized.
Research Focus
Key Achievements
Top Papers
- 1